RU2485132C2: Embryonic neural protein–polypeptide complex — RU2485132C2
A. B. Nazarenko, M. A. Sokolov · 2013 · RU2485132C2 · patent family 47259597
Published 2013-06-20.
Reported patent results
Reported findings
Ungulate embryonic neural-tissue protein–polypeptide complex and a composition containing nucleotide material.
Applicant characterization and supporting test disclosures. Analytical claim parameters are distinguishable from experiment outcomes.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Example 11 · rat survival after bilateral carotid ligation | 34/36 after injected complex versus 9/24 untreated controls | Intraperitoneal 0.2 mg/kg at one and five hours, as described. Applicant reports p≤0.01 versus control. |
| Example 11 · intranasal count conflict | Narrative 30/36 survivors; Table 1 prints 32/36 with 6 deaths and 83% | The nasal arm cannot be reconciled from the filing. Timing and exposure also differ from the injected arm. |
| Protein–polypeptide range | 0.5–200 kDa, with ≥70% in 20–160 kDa range | Claimed composition and characterization specification. |
| Separate nucleotide component | 12–1,000 kDa as printed | The pharmaceutical composition includes a separate nucleotide fraction. No clinical effect inferred. |
Separately manufactured patent-defined product. Cortexin and Cerebrolysin are background comparators, and the filing does not establish equivalence to PPK-V.
Source for the extracted data ↗ · Checked 2026-11-09
Patent claims and provenance
Formulation. Ungulate embryonic neural-tissue protein–polypeptide complex and a composition containing nucleotide material.
Separately manufactured patent-defined product. Cortexin and Cerebrolysin are background comparators, and the filing does not establish equivalence to PPK-V.
- Publication
- RU2485132C2 ↗ · 2013-06-20
- Earliest priority / filing
- 2011-05-30 / 2011-05-30
- Original applicant / assignee
- Not established from accessed metadata
- Indexed status
- Not shown; official status unverified · checked 2026-11-09
- Patent family
- 47259597 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Белково-полипептидный комплекс с антигипоксическим и репаративным действием, способ его получения и фармацевтическая композиция
Inventors: A. B. Nazarenko; M. A. Sokolov.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Separately manufactured patent-defined product. Cortexin and Cerebrolysin are background comparators, and the filing does not establish equivalence to PPK-V.
- Separately manufactured patent-defined product. Cortexin and Cerebrolysin are background comparators, and the filing does not establish equivalence to PPK-V.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-47259597. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-09. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: A. B. Nazarenko, M. A. Sokolov. RU2485132C2: Embryonic neural protein–polypeptide complex — RU2485132C2 RU2485132C2 · patent family 47259597 2013.
Molekul research summary: https://molekul.io/research/patent-ru2485132c2. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry